Trial Profile
Efficacy of add-on pregabalin in the treatment of Generalized Anxiety Disorder comorbid with Major Depressive Disorder: a double-blind placebo-controlled study
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 06 Sep 2018
Price :
$35
*
At a glance
- Drugs Pregabalin (Primary) ; Escitalopram
- Indications Generalised anxiety disorder; Major depressive disorder
- Focus Therapeutic Use
- 31 Aug 2018 Primary endpoint (Trail Making Test Part B) has not been met, according to results published in the Pharmacopsychiatry.
- 31 Aug 2018 Primary endpoint (State-Trait Anxiety Inventory) has not been met, according to results published in the Pharmacopsychiatry.
- 31 Aug 2018 Results published in the Pharmacopsychiatry.